Takeda has officially taken over Shire in a deal that could re-establish the trend for mega mergers in big pharma. The merger was approved yesterday in a court hearing in Jersey, where Shire was ...

Prior to Takeda’s bid, Shire’s stock was low, mainly because investors have been unimpressed by its $32 billion takeover of rare diseases specialist Baxalta in 2016.

Ricci has spent his entire technology career in the pharmaceutical industry, beginning at Bristol-Myers Squibb, then Johnson ...

Takeda has reached a deal to buy Adderall drugmaker Shire for $64.3 billion. The deal comes after a handful of rejections from Shire and a short-lived potential for a bidding war between Takeda ...

TOKYO: The rapidly changing global pharmaceutical landscape reached another milestone as Takeda Pharmaceutical Co completed its US$62bil acquisition of Shire Plc. Takeda’s purchase was the world ...

Takeda Pharmaceutical named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but growing ranks of women leading Japanese companies.